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Evaluation of the calcium-sensing receptor gene in idiopathic probably a polygenic trait [3] associated with increased
hypercalciuria and calcium nephrolithiasis. urine calcium excretion [idiopathic hypercalciuria (IH)]
Background. Calcium urolithiasis is in part genetically de- in up to 40% of stone formers. The genetic basis of IHtermined and associated with idiopathic hypercalciuria.
is largely unknown.Methods. We have used a candidate gene approach to deter-
The calcium-sensing receptor (CaR) is a candidatemine whether the calcium-sensing receptor (CaR) gene is
linked to idiopathic hypercalciuria and calcium urolithiasis in gene for IH. This G-protein–coupled receptor is ex-
a cohort of French Canadian sibships with multiple affected pressed in parathyroid glands and kidneys and is a key
members (64 sibships from 55 pedigrees yielding 359 affected regulator of parathyroid hormone (PTH) secretion and
sibling pairs with $1 stone episode).
renal tubular calcium reabsorption according to extracel-Results. Using nonparametric linkage analysis with various
lular calcium concentration [7]. In the parathyroid gland,intragenic and flanking markers, we showed that the CaR gene
could be excluded as a major gene for hypercalciuric stone the CaR induces inhibition of PTH secretion upon bind-
formation. We excluded the CaR (lod score ,22) at ls values ing of calcium. In the kidney, the CaR is highly expressed
of 1.5, 1.68, and 2.6 for sib pairs concordant for at least one in multiple nephron segments, including medullar and
stone passage, at least two stone passages, and at least one stone
cortical thick ascending limbs, proximal and distal convo-passage and calciuria above the 75th percentile, respectively.
luted tubules, and inner medullary collecting duct [8],Quantitative trait linkage analyses did not suggest that the
CaR gene was linked to biochemical markers of idiopathic where it regulates renal tubular calcium reabsorption.
hypercalciuria. In addition, the CaR is involved in urine concentration
Conclusions. This study shows that genetic variants of the and dilution, as it inhibits the action of vasopressin to
CaR gene are not associated with idiopathic hypercalciuria and
balance the need for excreting calcium and conservingcalcium nephrolithiasis in this population of French Canadians.
water [9]. Genetic variation at the CaR locus is linked
to urine calcium excretion in rare monogenic traits, in-
cluding familial benign hypercalcemia, neonatal severeThe passage of a kidney stone (nephrolithiasis) is a
hyperparathyroidism, and an autosomal dominant formcommon event that will affect 5 to 15% of the North
of hypocalcemia [10–13].American population. In the United States, complica-
We present the results of a sib-pair linkage analysistions related to nephrolithiasis represent 1% of all hospi-
of the CaR locus in a large group of French Canadiantalizations and have an important economic impact [1].
sibships. We tested this locus for linkage to calcium stoneThe most common type of nephrolithiasis is composed
formation and quantitative phenotypes relevant to cal-of calcium, either as an oxalate or phosphate salt alone,
cium metabolism.or as a combination of both. Familial aggregation studies
suggest that genetic factors underlie stone formation
[2–6]. A positive family history is a strong risk factor METHODS
[6], and the passage or formation of calcium stones is Pedigrees and phenotyping
All families in the study were of French Canadian
descent and were recruited from several specializedKey words: kidney stones, urolithiasis, sib-pair linkage analysis, chro-
mosome 3, familial hypercalciuria. stone clinics and lithotripsy units as described [14]. All
subjects gave informed consent and were interviewed byReceived for publication June 8, 1999
a member of the study. A single 24-hour urine collectionand in revised form December 28, 1999
Accepted for publication January 17, 2000 under a free diet and a calcium-loading test were per-
formed. Standard biochemical analyses on urine and se-Ó 2000 by the International Society of Nephrology
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Table 1. Number of calcium stone-forming families and sibships Molecular and statistical genetics
At least 1 At least 2 We physically mapped the CaR gene and three flanking
stone passage stone passages Trait T75a
N affected siblings highly polymorphic markers from Genethon (D3S1278,
per sibship N sibships D3S3515, and D3S1551) by radiation hybrid mapping
2 28 18 8 using a commercially available panel (GeneBridge 4
3 13 17 6 panel; Research Genetics, Huntsville, AL, USA) and4 6 4 1
polymerase chain reaction (PCR) methods. The RHMAP5 9 3 2
6 6 — — program was used to order all sequence tag sites [16].
7 1 — — Genotyping was performed on genomic DNA extracted11 1 1 —
from peripheral leukocytes by a salting-out procedure [17].Total N sibships
(families) 64 (55) 43 (41) 17 (17) Amplifications of three multiallelic markers spanning the
aAffected siblings for the trait T75 had at least one stone passage and calciuria CaR gene locus and two intragenic markers of the CaR
above the 75th percentile in our database gene were performed by polymerase chain reaction/elec-
trophoresis methods. The intragenic markers consisted in
two biallelic polymorphisms, A986S and G990R [18], am-
plified in a single fragment using primers CaR3343S (59-rum samples were performed, as described [14]. Each
CAGCCCAGATGCAAGCAGAA-39) and CaR3500Raffected proband had at least one calcium stone episode
(59-TGGTGTCGGGTCAGCGTAT-39). We used single-verified by crystallographic (pure calcium oxalate or
strand conformation polymorphism (SSCP) to resolvecombined calcium oxalate-calcium phosphate) or bio-
genotypes. The construction of genetic maps was carriedchemical analysis when available. Overall, crystallo-
out with the CRIMAP and MULTIMAP programs [19, 20].graphic analysis was available for 56% of probands (31
Genetic and quantitative trait linkage (QTL) analysesout of 55), biochemical analysis for 25% (14 out of 55).
on intermediate phenotypes relevant to calcium homeo-In 10 of the 55 patients (18%), no stone analysis was
stasis were performed with the MAPMAKER/SIBS pro-
available, so calcium stone episodes were verified by intra-
gram, version 2.1 [21] with the “all pairs” option weighted
venous pyelogram (radiodense stone). Available hospital
by sibship size. The aim was to determine whether com-
records (abdominal ultrasound studies and x-ray film)
mon genetic variations at the CaR locus specify particu-
were reviewed to confirm unaffected status for healthy lar quantitative phenotypes.
relatives. Individuals with a history of urinary tract in-
fection or with any secondary condition that might pre-
RESULTSdispose to kidney stones (that is, inflammatory bowel
disease, hyperparathyroidism) were attributed an unde- Mapping
termined affection status. A sequence tag of the CaR gene was assigned to chro-
The cohort consisted of 55 pedigrees (64 sibships) mosome 3q13.3-q21, confirming previous results [22].
comprising 359 pairs of affected siblings with at least The D3S3515 marker was closest to the CaR gene. The
one stone episode (Table 1). We defined “more severe” distance between both sequence tag sites was 0.105 rays
(at least 2 stone passages) and semiquantitative (at least (approximately 3.15 cM) with a lod score .17. The ge-
1 stone passage with calciuria above the 75th percentile, netic map constructed spanned an 11.8 cM region with
trait “T75”) affection statuses, yielding 196 and 52 pairs the following order: D3S1278-D3S3515-(A986S-G990R)-
of affected siblings, respectively (Table 1). For the sec- D3S1551 at distances of 5.4, 3.5, and 2.9 cM, respectively.
ond affection status (at least 2 stone passages), subjects The support for this order (lod score) was 2.99 log above
with only one stone episode were assigned an undeter- the next best order.
mined affection status. We used “more severe” pheno-
types to enhance the putative genetic susceptibility in Linkage analysis
affected pairs of siblings. For the trait T75, every affected Multipoint sib-pair linkage analyses did not show evi-
sib in a sib pair had at least one stone episode and a 24- dence for linkage between the CaR gene and calcium
hour calciuria above 0.102 mmol/kg/d (urine collections stone passage (at least 1 stone passage and at least 2
with 24-h creatinine excretion within 20% of that pre- stone passages) in the total group. Furthermore, affected
dicted by the Cockcroft-Gault formula) [15]. When 24- pairs of siblings concordant for calciuria above the 75th
hour collections were inadequately performed, fasting percentile (traits T75) did not show evidence for linkage.
urine calcium/creatinine ratios were used (T75 5 value The option “estimate” of MAPMAKERS/SIBS was used
above 0.513 mmol/mmol). Table 2 shows clinical charac- to determine allele sharing in affected sib pairs. The
teristics of affected and unaffected siblings for all three proportion of affected sib pairs sharing 0, 1, and 2 alleles
at the CaR loci was identical to theoretical values undertraits.
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Table 2. Clinical characteristics of siblings in pedigrees with calcium and/or radiopaque nephrolithiasis
At least 1 stone passage At least 2 stone passages Trait T75a
Status Unaffected Affected P value Affected P value Affected P value
Serum calcium 2.3360.10 2.3160.15 0.13 2.3160.13 0.28 2.3460.10 0.41
mmol/L 245 282 187 80
Serum PTH 3.1261.62 3.1561.48 0.83 3.2461.62 0.46 2.8661.304 0.21
pmol/L 229 263 172 74
Calciuriab 0.06760.034 0.08960.046 0.00002 0.09160.043 8.75E-06 0.13560.033 1.60E-25
mmol/kg/d 109 169 114 58
Fasting Ca/Cr 0.3860.250 0.43460.323 0.05 0.44060.333 0.06 0.62160.263 2.13E-11
mmol/mmol 181 245 164 77
D Ca/Cr 0.50060.359 0.59660.631 0.12 0.63160.698 0.06 0.67460.369 0.003
mmol/mmol 128 196 128 56
All values are mean 6 SD (and number of individuals indicated below); D Ca/Cr, difference between post-calcium load ratio and fasting ratio.
aAffected siblings for the trait T 75 had at least 1 stone passage and calciuria above the 75th percentile in our database
b24-Hour urine collections with variation in measured creatinine content within 20% of predicted (Cockcroft-Gault estimation [15])
Fig. 1. Exclusion mapping of the calcium
sensing receptor (CaR) loci. Lod scores were
obtained with the “exclude” option of MAP-
MAKER/SIBS at specific relative risk (ls)
values for which the maximum lod score did
not exceed 22.0 over the interval.
the null hypothesis (0.25, 0.50, and 0.25) for all three on serum calcium, parathyroid hormone (PTH) and
traits studied (data not shown). The “exclude” option of 1,25(OH)2D3, fasting and postloading calciuria (before
MAPMAKERS/SIBS was used to determine the sibling and after the ingestion of 1 g of elemental calcium),
relative risks (ls) for which we have excluded (lod and 24-hour urine calcium excretion. Table 3 shows the
score ,22.0) the CaR gene in our population (Fig. 1). results of QTL analyses in our families. No significant
The l ratios were 1.50, 1.68, and 2.6, respectively, for linkage was detected for any of the quantitative traits
the aforementioned affection statuses. This suggests that considered.
the CaR gene is neither linked to urine calcium excretion
nor to calcium stone passage in our hypercalciuric sib-
DISCUSSIONships. Finally, the option “infomap” was used to calculate
We have used a candidate gene approach to determinethe information content mapping. The information con-
whether the CaR gene on chromosome 3q is linked totents of the loci were above 0.85 for all three traits.
urinary calcium excretion phenotypes and/or calcium
Quantitative trait locus mapping stone formation in a group of French Canadian pedi-
grees. We analyzed the genetic data with the affectedTo determine whether genetic variation at the CaR
sib-pair method, as it is well suited to situations in whichlocus might modulate intermediate phenotypes related
to calcium metabolism, we performed QTL analyses inheritance is complex or unknown. The results suggest
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Table 3. Quantitative trait linkage (QTL) analysis of the CaR locus the vitamin D receptor on chromosome 12 might be
with phenotypic traits relevant to calcium nephrolithiasis
linked to this trait [28]. As the list of relevant candidate
QTL P valuesa genes decreases, further studies should involve a more
Serum Ca 0.133 comprehensive “genome wide” approach.
PTH 0.632
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